Sjögren-szindróma: vizsgálatok itt: Hollandia
6 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 12.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleTwo Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
- Where
- Almelo, Groningen, Leeuwarden, Rotterdam
- Életkor
- 18 év and over
- People
- 570 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07621809 · EU 2025-522271-29-00 - 2. fázisTaking peopleA Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease
- Where
- Groningen, Utrecht
- Életkor
- 18 év to 100 év
- People
- 344 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07737743 · EU 2025-524513-92-00 - 3. fázisTaking peoplePhase 3 Study of Telitacicept in Active Primary Sjögren's Disease
- Where
- Amsterdam, Leeuwarden
- Életkor
- 18 év to 75 év
- People
- 250 worldwide
- Run by
- Vor Biopharma
See details and how to joinNCT07404865 · EU 2026-525556-28-00 - 1. fázisNot yet taking people in HollandiaA Study of BMS-986553 in Participants With Refractory Autoimmune Diseases
- Where
- Amsterdam, Leiden
- Életkor
- 18 év and over
- People
- 60 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07873931 - 2. fázisNot yet taking people in HollandiaUltimate dePletion of autoReactive b cells using Obinutuzumab from sjÖgren's syndrome affected Tissues study- UPROOT study
- Where
- Nijmegen
- Életkor
- 18 év and over
- People
- 10
- Run by
- Radboud universitair medisch centrum Stichting
See details and how to join2024-519884-16-00 · EU 2024-519884-16-00 - 1. fázisTaking peopleA Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)
- Where
- Amsterdam, Utrecht
- Életkor
- 18 év to 75 év
- People
- 36 worldwide
- Run by
- AbbVie
See details and how to joinNCT06977724 · EU 2024-519157-10-00